Compare Stocks: BNGO, CSBR, RPID, and IBAC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNGO Bionano Genomics	$1.83 +5.8%	$1.22	$1.00 ▼ $2.23	$20.37M	1.65	2.40 million shs	977,483 shs
CSBR Champions Oncology	$5.26 -0.8%	$5.30	$4.59 ▼ $8.31	$73.77M	0.4	12,535 shs	10,391 shs
IBAC IB Acquisition	$11.04 -5.2%	$10.85	$10.19 ▼ $11.64	$58.30M	N/A	1,874 shs	5,207 shs
RPID Rapid Micro Biosystems	$1.13 +0.9%	$1.68	$1.09 ▼ $4.94	$56.18M	1.43	255,739 shs	260,149 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNGO Bionano Genomics	+5.78%	+37.59%	+52.50%	+59.13%	+2.23%
CSBR Champions Oncology	-0.75%	+6.91%	+6.05%	-15.57%	-19.94%
IBAC IB Acquisition	-5.15%	+1.20%	+1.47%	+3.27%	+4.30%
RPID Rapid Micro Biosystems	+0.89%	-3.42%	-32.74%	-33.14%	-66.47%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNGO Bionano Genomics	$1.83 +5.8%	$1.22	$1.00 ▼ $2.23	$20.37M	1.65	2.40 million shs	977,483 shs
CSBR Champions Oncology	$5.26 -0.8%	$5.30	$4.59 ▼ $8.31	$73.77M	0.4	12,535 shs	10,391 shs
IBAC IB Acquisition	$11.04 -5.2%	$10.85	$10.19 ▼ $11.64	$58.30M	N/A	1,874 shs	5,207 shs
RPID Rapid Micro Biosystems	$1.13 +0.9%	$1.68	$1.09 ▼ $4.94	$56.18M	1.43	255,739 shs	260,149 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNGO Bionano Genomics	+5.78%	+37.59%	+52.50%	+59.13%	+2.23%
CSBR Champions Oncology	-0.75%	+6.91%	+6.05%	-15.57%	-19.94%
IBAC IB Acquisition	-5.15%	+1.20%	+1.47%	+3.27%	+4.30%
RPID Rapid Micro Biosystems	+0.89%	-3.42%	-32.74%	-33.14%	-66.47%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNGO Bionano Genomics	2.00	Hold	$6.00	227.87% Upside
CSBR Champions Oncology	1.00	Sell	N/A	N/A
IBAC IB Acquisition	1.00	Sell	N/A	N/A
RPID Rapid Micro Biosystems	2.33	Hold	$6.00	430.97% Upside

Current Analyst Ratings Breakdown

Latest BNGO, CSBR, RPID, and IBAC Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/16/2026	CSBR Champions Oncology	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D)
9/2/2026	BNGO Bionano Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
8/27/2026	IBAC IB Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/18/2026	BNGO Bionano Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
8/14/2026	IBAC IB Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
7/29/2026	BNGO Bionano Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	RPID Rapid Micro Biosystems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/30/2026	CSBR Champions Oncology	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 9/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNGO Bionano Genomics	$28.51M	0.76	N/A	N/A	$4.37 per share	0.42
CSBR Champions Oncology	$59.42M	1.23	$0.01 per share	364.36	$0.29 per share	18.14
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
RPID Rapid Micro Biosystems	$33.59M	1.69	N/A	N/A	$0.75 per share	1.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNGO Bionano Genomics	-$26.40M	-$3.02	N/A	N/A	N/A	-106.58%	-78.78%	-48.54%	10/29/2026 (Estimated)
CSBR Champions Oncology	-$1.17M	-$0.08	N/A	N/A	N/A	-1.82%	-25.77%	-3.71%	N/A
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RPID Rapid Micro Biosystems	-$47.12M	-$1.12	N/A	N/A	N/A	-145.56%	-177.04%	-73.12%	11/6/2026 (Estimated)

Latest BNGO, CSBR, RPID, and IBAC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/10/2026	Q1 2027	CSBR Champions Oncology	-$0.01	$0.05	+$0.06	-$0.03	$15.05 million	$15.23 million
8/14/2026	Q3 2026	IBAC IB Acquisition	N/A	-$0.11	N/A	-$0.11	N/A	N/A
8/10/2026	Q2 2026	BNGO Bionano Genomics	-$0.67	-$0.64	+$0.03	-$0.64	$7.55 million	($6.67) million
8/7/2026	Q2 2026	RPID Rapid Micro Biosystems	-$0.2433	-$0.27	-$0.0267	-$0.27	$7.88 million	$8.05 million
7/27/2026	Q4 2026	CSBR Champions Oncology	-$0.05	$0.01	+$0.06	-$0.05	$12.89 million	$13.84 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNGO Bionano Genomics	N/A	N/A	N/A	N/A	N/A
CSBR Champions Oncology	N/A	N/A	N/A	N/A	N/A
IBAC IB Acquisition	N/A	N/A	N/A	N/A	N/A
RPID Rapid Micro Biosystems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNGO Bionano Genomics	0.11	2.48	1.96
CSBR Champions Oncology	N/A	1.03	1.03
IBAC IB Acquisition	N/A	N/A	N/A
RPID Rapid Micro Biosystems	1.08	2.55	1.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BNGO Bionano Genomics	11.35%
CSBR Champions Oncology	41.30%
IBAC IB Acquisition	N/A
RPID Rapid Micro Biosystems	52.60%

Insider Ownership

Company	Insider Ownership
BNGO Bionano Genomics	0.65%
CSBR Champions Oncology	46.30%
IBAC IB Acquisition	N/A
RPID Rapid Micro Biosystems	12.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BNGO Bionano Genomics	97	11.78 million	11.70 million	No Data
CSBR Champions Oncology	214	13.92 million	7.48 million	Optionable
IBAC IB Acquisition	2	5.01 million	N/A	N/A
RPID Rapid Micro Biosystems	171	50.16 million	43.79 million	Not Optionable

BNGO, CSBR, RPID, and IBAC Headlines

Recent News About These Companies

Comparing Thermo Fisher Scientific (NYSE:TMO) and Rapid Micro Biosystems (NASDAQ:RPID)

September 21 at 4:29 AM | americanbankingnews.com

Reviewing MaxCyte (NASDAQ:MXCT) & Rapid Micro Biosystems (NASDAQ:RPID)

September 14, 2026 | americanbankingnews.com

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

September 4, 2026 | globenewswire.com

After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)

September 4, 2026 | zacks.com

Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID)

August 19, 2026 | zacks.com

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

August 12, 2026 | zacks.com

Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary

August 8, 2026 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2026 | zacks.com

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

August 7, 2026 | globenewswire.com

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 4, 2026 | globenewswire.com

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

July 23, 2026 | globenewswire.com

Rapid Micro Biosystems (RPID)

June 24, 2026 | zacks.com

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 10, 2026 | markets.businessinsider.com

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 10, 2026 | globenewswire.com

Rapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potential

May 19, 2026 | msn.com

Rapid Micro Biosystems Announces Pricing of $9.8 Million Underwritten Public Offering of Class A Common Stock and Warrants

May 18, 2026 | quiverquant.comQ

Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering

May 18, 2026 | globenewswire.com

Rapid Micro Biosystems Earnings Call Balances Growth And Risk

May 16, 2026 | theglobeandmail.com

Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript

May 14, 2026 | finance.yahoo.com

Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...

May 14, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNGO, CSBR, RPID, and IBAC Company Descriptions

Bionano Genomics NASDAQ:BNGO

$1.83 +0.10 (+5.78%)

As of 09/21/2026 04:00 PM Eastern

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Champions Oncology NASDAQ:CSBR

$5.26 -0.04 (-0.75%)

As of 09/21/2026 04:00 PM Eastern

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

IB Acquisition NASDAQ:IBAC

$11.04 -0.60 (-5.15%)

As of 09/21/2026 03:53 PM Eastern

IB Acquisition Corp. is a blank check company. It formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. IB Acquisition Corp. is based in Boca Raton, Florida.

Rapid Micro Biosystems NASDAQ:RPID

$1.13 +0.01 (+0.89%)

As of 09/21/2026 04:00 PM Eastern

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BNGO, CSBR, RPID, and IBAC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BNGO, CSBR, RPID, and IBAC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BNGO, CSBR, RPID, and IBAC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNGO, CSBR, RPID, and IBAC Company Descriptions

Bionano Genomics NASDAQ:BNGO

Champions Oncology NASDAQ:CSBR

IB Acquisition NASDAQ:IBAC

Rapid Micro Biosystems NASDAQ:RPID

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BNGO, CSBR, RPID, and IBAC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BNGO, CSBR, RPID, and IBAC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BNGO, CSBR, RPID, and IBAC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNGO, CSBR, RPID, and IBAC Company Descriptions

Bionano Genomics NASDAQ:BNGO

Champions Oncology NASDAQ:CSBR

IB Acquisition NASDAQ:IBAC

Rapid Micro Biosystems NASDAQ:RPID

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools